Can Antares Pharma Inc (ATRS) Stock Rise to the Top of Healthcare Sector Friday?

Friday, November 12, 2021 11:13 AM | InvestorsObserver Analysts

Mentioned in this article

Can Antares Pharma Inc (ATRS) Stock Rise to the Top of Healthcare Sector Friday?

Antares Pharma Inc (ATRS) is around the top of the Healthcare sector according to InvestorsObserver. ATRS received an overall rating of 49, which means that it scores higher than 49% of stocks. Additionally, Antares Pharma Inc scored a 83 in the Healthcare sector, ranking it higher than 83% of stocks in that sector.

ATRS has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on ATRS!

See Full ATRS Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Antares Pharma Inc Stock Today?

Antares Pharma Inc (ATRS) stock is down -2.26% while the S&P 500 is higher by 0.43% as of 11:12 AM on Friday, Nov 12. ATRS has fallen -$0.09 from the previous closing price of $3.76 on volume of 196,591 shares. Over the past year the S&P 500 has gained 32.01% while ATRS is higher by 28.67%. ATRS earned $0.38 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 9.78. Click Here to get the full Stock Report for Antares Pharma Inc stock.